HIV 1 News and Research

RSS
New class of CXCR4 antagonists could prevent airway inflammation and atopic dermatitis

New class of CXCR4 antagonists could prevent airway inflammation and atopic dermatitis

Metabolic restoration as a therapeutic approach to promote natural immune protection against HIV

Metabolic restoration as a therapeutic approach to promote natural immune protection against HIV

Research reveals components of Sinbis virus ribonucleoproteins

Research reveals components of Sinbis virus ribonucleoproteins

Research finds different antibody responses following COVID vaccination and natural infection

Research finds different antibody responses following COVID vaccination and natural infection

Researchers identify new biomarker for severe COVID-19

Researchers identify new biomarker for severe COVID-19

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

Potent extended anti- SARS-CoV-2 effect of titanium dioxide surface coatings

Critical function of IL-7 in diagnosis, prognosis, and treatment of COVID-19 patients

Critical function of IL-7 in diagnosis, prognosis, and treatment of COVID-19 patients

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

Cysteamine inhibits SARS-CoV-2 variants of concern in vitro

Hyperbranched polylysine nanopolymer as potential broad-spectrum antiviral against SARS-CoV-2

Hyperbranched polylysine nanopolymer as potential broad-spectrum antiviral against SARS-CoV-2

People with natural immunity and subsequent mRNA vaccination can neutralize viral particles capable of resisting vaccine-induced antibodies

People with natural immunity and subsequent mRNA vaccination can neutralize viral particles capable of resisting vaccine-induced antibodies

Temple research paves the way for first Phase 1/2 clinical trials of CRISPR-based therapy for HIV

Temple research paves the way for first Phase 1/2 clinical trials of CRISPR-based therapy for HIV

Polymeric and lipid nanoparticles in self-amplifying RNA vaccines result in higher protein expression and immunogenicity

Polymeric and lipid nanoparticles in self-amplifying RNA vaccines result in higher protein expression and immunogenicity

COVID booster shots might be needed in subgroup of HIV-positive individuals

COVID booster shots might be needed in subgroup of HIV-positive individuals

Certain intestinal bacteria induce cross-reactive IgA responses to the SARS-CoV-2 spike RBD

Certain intestinal bacteria induce cross-reactive IgA responses to the SARS-CoV-2 spike RBD

Antibody responses following SARS-CoV-2 infection more potent than vaccine-elicited ones

Antibody responses following SARS-CoV-2 infection more potent than vaccine-elicited ones

Antiviral activity of long-chain polyphosphates against SARS-CoV-2 infection

Antiviral activity of long-chain polyphosphates against SARS-CoV-2 infection

Study explores lectins from plants, fungi, algae and cyanobacteria as pan-coronavirus inhibitors

Study explores lectins from plants, fungi, algae and cyanobacteria as pan-coronavirus inhibitors

New biomarkers can predict HIV remission after antiretroviral therapy interruption

New biomarkers can predict HIV remission after antiretroviral therapy interruption

Indian SARS-CoV-2 variant has unique infection and immune escape strategy say researchers

Indian SARS-CoV-2 variant has unique infection and immune escape strategy say researchers

Texas Biomed scientists receive $1 million NIH funding for Ebola research

Texas Biomed scientists receive $1 million NIH funding for Ebola research

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.